Guizhou Bailing (002424) Investor Compensation Case Filed Again in Court, Precedents of Successful Claims Exist for Certain Periods

Deep News11-21

Investors affected by Guizhou Bailing Group Pharmaceutical Co., Ltd. (002424) can register their claims on the Sina Investor Rights Protection Platform.

On November 20, 2025, lawyer Xu Feng from Shanghai Jiucheng Law Firm submitted another batch of investor compensation cases related to Guizhou Bailing's (002424) false statements to the court. Earlier cases have already entered the mediation process.

Xu Feng's legal team has previously filed multiple claims for Guizhou Bailing investors, and the cases are now awaiting further court arrangements. The team continues to process subsequent filings and is still accepting new investor claims.

On November 8, 2024, Guizhou Bailing announced that it had received a "Notice of Investigation" from the China Securities Regulatory Commission (CSRC) due to suspected violations of information disclosure regulations. The CSRC initiated an investigation under the Securities Law and Administrative Penalty Law.

Earlier, on June 4, 2024, the company disclosed that it had received a "Warning Letter" from the Guizhou Securities Regulatory Bureau. The letter stated that Guizhou Bailing had failed to issue an earnings forecast as required after its audited net profit attributable to shareholders showed a loss of 415 million yuan in its 2023 annual report, released on April 30, 2024.

Lawyer Xu Feng believes that investors who purchased Guizhou Bailing shares between April 23, 2022, and April 30, 2024, and sold or held them after April 30, 2024, may still file claims. Some cases from specific periods have already resulted in successful judgments.

(Note: This article is provided by lawyer Xu Feng of Shanghai Jiucheng Law Firm and does not represent the views of Sina Finance. Xu Feng has been practicing law since 2008, specializing in securities fraud claims, including false statements, insider trading, and market manipulation. Over the years, his team has secured compensation for investors in nearly 200 stock cases through litigation or mediation, with hundreds more currently in progress.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment